Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Franck Toledo

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
International Journal of Molecular Sciences|July 12, 2025
Mutant p53 as a Therapeutic Target: The Report of Its Death Was an ExaggerationFranck Toledo
Cancers|December 18, 2020
Mechanisms Generating Cancer Genome Complexity: Back to the FutureFranck Toledo
Genes|February 24, 2017
Targeting MDM4 Splicing in CancersBoris Bardot, Franck Toledo
Cancers|May 9, 2018
The Guardian of the Genome Revisited: p53 Downregulates Genes Required for Telomere Maintenance, DNA Repair, and Centromere StructureEléonore Toufektchan, Franck Toledo
International Journal of Molecular Sciences|October 14, 2023
p53 in the Molecular Circuitry of Bone Marrow Failure SyndromesJeanne Rakotopare, Franck Toledo
The International Journal of Biochemistry & Cell Biology|May 15, 2007
MDM2 and MDM4: p53 regulators as targets in anticancer therapyFranck Toledo, Geoffrey M Wahl
Nature Reviews. Cancer|November 28, 2006
Regulating the p53 pathway: in vitro hypotheses, in vivo veritasFranck Toledo, Geoffrey M Wahl
Cell Cycle (Georgetown, Tex.)|December 6, 2003
Replication initiation in mammalian cells: changing preferencesMichelle Debatisse, Franck Toledo, Mauro Anglana
Nature Communications|April 2, 2016
p53 downregulates the Fanconi anaemia DNA repair pathwaySara Jaber, Eléonore Toufektchan, Vincent Lejour, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 12, 2005
The C-terminal lysines fine-tune P53 stress responses in a mouse model but are not required for stability control or transactivationKurt A Krummel, Crystal J Lee, Franck Toledo, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
International Journal of Molecular Sciences|July 12, 2025
Mutant p53 as a Therapeutic Target: The Report of Its Death Was an ExaggerationFranck Toledo
Cancers|December 18, 2020
Mechanisms Generating Cancer Genome Complexity: Back to the FutureFranck Toledo
Genes|February 24, 2017
Targeting MDM4 Splicing in CancersBoris Bardot, Franck Toledo
Cancers|May 9, 2018
The Guardian of the Genome Revisited: p53 Downregulates Genes Required for Telomere Maintenance, DNA Repair, and Centromere StructureEléonore Toufektchan, Franck Toledo
International Journal of Molecular Sciences|October 14, 2023
p53 in the Molecular Circuitry of Bone Marrow Failure SyndromesJeanne Rakotopare, Franck Toledo
The International Journal of Biochemistry & Cell Biology|May 15, 2007
MDM2 and MDM4: p53 regulators as targets in anticancer therapyFranck Toledo, Geoffrey M Wahl
Nature Reviews. Cancer|November 28, 2006
Regulating the p53 pathway: in vitro hypotheses, in vivo veritasFranck Toledo, Geoffrey M Wahl
Cell Cycle (Georgetown, Tex.)|December 6, 2003
Replication initiation in mammalian cells: changing preferencesMichelle Debatisse, Franck Toledo, Mauro Anglana
Nature Communications|April 2, 2016
p53 downregulates the Fanconi anaemia DNA repair pathwaySara Jaber, Eléonore Toufektchan, Vincent Lejour, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 12, 2005
The C-terminal lysines fine-tune P53 stress responses in a mouse model but are not required for stability control or transactivationKurt A Krummel, Crystal J Lee, Franck Toledo, et al.
Pageof 3